BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21802879)

  • 1. Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs.
    Moffett SE; Frazee BW; Stein JC; Navab B; Maselli J; Takhar SS; Gonzales R
    Am J Emerg Med; 2012 Jul; 30(6):942-9. PubMed ID: 21802879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
    Caterino JM; Weed SG; Espinola JA; Camargo CA
    Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
    Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
    J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of quinolone resistance among urinary tract infections in the ED.
    Khawcharoenporn T; Vasoo S; Ward E; Singh K
    Am J Emerg Med; 2012 Jan; 30(1):68-74. PubMed ID: 21075586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
    Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
    Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
    BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing antibiotic resistance.
    Gupta K
    Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
    Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
    Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country.
    Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M
    Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract infection: traditional pharmacologic therapies.
    Nicolle LE
    Dis Mon; 2003 Feb; 49(2):111-28. PubMed ID: 12601341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expanding role of fluoroquinolones.
    Schaeffer AJ
    Dis Mon; 2003 Feb; 49(2):129-47. PubMed ID: 12601342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of Escherichia coli urinary isolates in ED-treated patients from a community hospital.
    Fleming VH; White BP; Southwood R
    Am J Emerg Med; 2014 Aug; 32(8):864-70. PubMed ID: 24877721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of urinary tract infections: historical perspective and current strategies: Part 2--Modern management.
    Nickel JC
    J Urol; 2005 Jan; 173(1):27-32. PubMed ID: 15592019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance of uncomplicated urinary tract infections in northern Utah.
    McQuilkin M; Lund A; Palmer W
    Clin Lab Sci; 2008; 21(2):99-101. PubMed ID: 18507303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of complicated urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Hawboldt J; Brooks A
    Postgrad Med; 2010 Nov; 122(6):7-15. PubMed ID: 21084776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection.
    Taur Y; Smith MA
    Clin Infect Dis; 2007 Mar; 44(6):769-74. PubMed ID: 17304445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.